Margaret Dah-Tsyr Chang Selected Research

Margaret Dah-Tsyr Chang Research Topics

Disease

11	Neoplasms (Cancer) 12/2020 - 09/2008
8	Asthma (Bronchial Asthma) 09/2013 - 09/2004
4	Inflammation (Inflammations) 01/2020 - 09/2008
2	Hepatocellular Carcinoma (Hepatoma) 04/2016 - 02/2005
2	Pneumonia (Pneumonitis) 02/2015 - 05/2013
2	Neoplasm Metastasis (Metastasis) 12/2013 - 06/2010
2	Uterine Neoplasms (Uterine Cancer) 05/2013 - 10/2012
2	Gliosarcoma 06/2009 - 05/2006
2	Severe Acute Respiratory Syndrome 07/2006 - 07/2005
1	Infections 01/2020
1	Chronic Hepatitis B 01/2018
1	Chromosomal Instability (Chromosome Stability) 04/2016
1	Parkinson Disease (Parkinson's Disease) 10/2013
1	Alzheimer Disease (Alzheimer's Disease) 10/2013
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 10/2013
1	Disease Progression 10/2013
1	Carcinoma (Carcinomatosis) 05/2013
1	Atherosclerosis 05/2013
1	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 01/2013
1	Sarcoma (Soft Tissue Sarcoma) 10/2012
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2012
1	Bacterial Infections (Bacterial Infection) 03/2010
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 06/2008
1	Superinfection 02/2005
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 09/2004

Drug/Important Bio-Agent (IBA)

13	Proteins (Proteins, Gene)FDA Link 12/2020 - 09/2004
8	Eosinophil Cationic ProteinIBA 01/2017 - 09/2004
7	Biomarkers (Surrogate Marker)IBA 10/2013 - 09/2004
3	Heparitin Sulfate (Heparan Sulfate)IBA 12/2020 - 05/2013
3	Pharmaceutical PreparationsIBA 12/2020 - 05/2013
3	Biological ProductsIBA 01/2020 - 05/2013
3	Cell-Penetrating PeptidesIBA 01/2020 - 01/2015
2	Hepatitis B Surface Antigens (HBsAg)FDA Link 01/2018 - 02/2005
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2015 - 08/2012
2	Heparan Sulfate Proteoglycans (Heparan Sulfate Proteoglycan)IBA 01/2015 - 05/2013
2	cathepsin SIBA 08/2014 - 06/2010
2	Doxorubicin (Adriamycin)FDA LinkGeneric 05/2013 - 10/2012
1	GlycosaminoglycansIBA 12/2020
1	Liposomes (Liposome)IBA 12/2020
1	Proteoglycans (Proteoglycan)IBA 12/2020
1	Peptides (Polypeptides)IBA 01/2020
1	Antiviral Agents (Antivirals)IBA 01/2018
1	CytokinesIBA 01/2017
1	Interleukin-13IBA 01/2017
1	InterleukinsIBA 01/2017
1	Methacholine Chloride (Methacholine)FDA Link 01/2017
1	Oncogene Proteins (Oncogene Protein)IBA 04/2016
1	CalciumIBA 04/2016
1	Surface Antigens (Surface Antigen)IBA 04/2016
1	CathepsinsIBA 08/2014
1	p38 Mitogen-Activated Protein KinasesIBA 12/2013
1	Bone Morphogenetic Proteins (Bone Morphogenetic Protein)IBA 12/2013
1	AutoantibodiesIBA 10/2013
1	HMGB1 Protein (HMG1)IBA 10/2013
1	Eosinophil-Derived NeurotoxinIBA 09/2013
1	Sulfhydryl Compounds (Thiols)IBA 05/2013
1	Cysteine (L-Cysteine)FDA Link 05/2013
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 05/2013
1	Radioisotopes (Radionuclides)IBA 05/2013
1	6-chloro-2-(1-piperazinyl)pyrazine (CPP)IBA 01/2013
1	ErbB Receptors (EGF Receptor)IBA 08/2012
1	Polysaccharides (Glycans)IBA 01/2012
1	Peptide Hydrolases (Proteases)FDA Link 06/2010
1	Anti-Bacterial Agents (Antibiotics)IBA 03/2010
1	Ribonucleases (Ribonuclease)IBA 01/2010
1	Protein Isoforms (Isoforms)IBA 06/2009
1	Heparin (Liquaemin)FDA LinkGeneric 09/2008
1	Calcimycin (A23187)IBA 06/2008
1	ThapsigarginIBA 06/2008
1	Endoplasmic Reticulum Chaperone BiPIBA 06/2008
1	Messenger RNA (mRNA)IBA 05/2006
1	geldanamycinIBA 05/2006
1	Histidine (L-Histidine)FDA Link 07/2005
1	MetalsIBA 07/2005
1	Hepatitis delta Antigens (HDAg)IBA 02/2005
1	DNA (Deoxyribonucleic Acid)IBA 02/2005
1	Eosinophil Granule ProteinsIBA 09/2004

Therapy/Procedure

5	Therapeutics 01/2018 - 09/2008
2	Drug Therapy (Chemotherapy) 05/2013 - 10/2012